2026 Summer Intern - Public Affairs & Access: Issue Advocacy & Alliances (US External Affairs) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Roche · 14 hours ago

2026 Summer Intern - Public Affairs & Access: Issue Advocacy & Alliances (US External Affairs)

Roche is a biotechnology company seeking a summer intern for their Public Affairs & Access department. The intern will support the Issue Advocacy & Alliances team in educating and engaging stakeholders while gaining experience in strategic advocacy plans and legislative priorities.

BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
check
Comp. & Benefits

Responsibilities

Attending external stakeholder events including but limited to: patient and provider policy summits, think tank briefings and trade association meetings
Engagement with external stakeholders to understand how key policies impact patients, their organizations and our business
Conduct research on external organization policy positions and support External Affairs team
Projects, events, and other activities as needed
Participate in team strategy sessions as we create advocacy plans on our key priorities

Qualification

US legislative processCouragePassionCommunication skillsCollaboration skillsInterpersonal skillsIntegrity

Required

Must be pursuing a Bachelor's degree
Must have attained a Bachelor's degree (recent graduates not currently enrolled in a grad program)
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Understanding of the US legislative process

Preferred

Political Science
Economics
Business Administration
Communications
Public Policy

Benefits

Paid holiday time off benefits

Company

Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.

Funding

Current Stage
Public Company
Total Funding
$7.79B
Key Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M

Leadership Team

leader-logo
Alan Hippe
Member of the Executive Board - Group CFO
linkedin
leader-logo
Christine Bakan
Global Head and VP of Software and Bioinformatics, Next Generation Sequencing
linkedin
Company data provided by crunchbase